121 related articles for article (PubMed ID: 16334170)
1. Serum levels of soluble syndecan-1 in Hodgkin's lymphoma.
Vassilakopoulos TP; Kyrtsonis MC; Papadogiannis A; Nadali G; Angelopoulou MK; Tzenou T; Dimopoulou MN; Siakantaris MP; Kontopidou FN; Kalpadakis C; Kokoris SI; Dimitriadou EM; Tsaftaridis P; Pizzolo G; Pangalis GA
Anticancer Res; 2005; 25(6C):4743-6. PubMed ID: 16334170
[TBL] [Abstract][Full Text] [Related]
2. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
Kyrtsonis MC; Vassilakopoulos TP; Siakantaris MP; Kokoris SI; Gribabis DA; Dimopoulou MN; Angelopoulou MK; Pangalis GA
Eur J Haematol; 2004 Apr; 72(4):252-8. PubMed ID: 15089762
[TBL] [Abstract][Full Text] [Related]
3. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.
Joensuu H; Anttonen A; Eriksson M; Mäkitaro R; Alfthan H; Kinnula V; Leppä S
Cancer Res; 2002 Sep; 62(18):5210-7. PubMed ID: 12234986
[TBL] [Abstract][Full Text] [Related]
4. Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival.
Lovell R; Dunn JA; Begum G; Barth NJ; Plant T; Moss PA; Drayson MT; Pratt G;
Br J Haematol; 2005 Aug; 130(4):542-8. PubMed ID: 16098068
[TBL] [Abstract][Full Text] [Related]
5. [Soluble syndecan-1 levels in different plasma cell dyscrasias].
Jánosi J; Sebestyén A; Mikala G; Petö M; Jákó J; Domján G; Németh J; Kis Z; Kopper L; Vályi-Nagy I
Orv Hetil; 2005 Jan; 146(4):165-8. PubMed ID: 15751511
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors.
Aref S; Goda T; El-Sherbiny M
Hematology; 2003 Aug; 8(4):221-8. PubMed ID: 12911939
[TBL] [Abstract][Full Text] [Related]
7. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of syndecan-1 in serum during acute graft-versus-host disease.
Seidel C; Ringdén O; Remberger M
Transplantation; 2003 Jul; 76(2):423-6. PubMed ID: 12883204
[TBL] [Abstract][Full Text] [Related]
9. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
10. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376
[TBL] [Abstract][Full Text] [Related]
11. Soluble syndecan-1 levels in different plasma cell dyscrasias and in different stages of multiple myeloma.
Jánosi J; Sebestyén A; Mikala G; Németh J; Kiss Z; Vályi-Nagy I
Haematologica; 2004 Mar; 89(3):370-1. PubMed ID: 15020284
[TBL] [Abstract][Full Text] [Related]
12. Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma.
Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Rassidakis GZ; Doussis-Anagnostopoulou IA; Hatzioannou M; Vaiopoulos G; Kittas C; Sarris AH; Pizzolo G; Pangalis GA
Haematologica; 2001 Mar; 86(3):274-81. PubMed ID: 11255274
[TBL] [Abstract][Full Text] [Related]
13. The significance of soluble CD138 in diagnosis of monoclonal gammopathies.
Maisnar V; Tousková M; Tichý M; Krejsek J; Chrobák L; Voglová J; Malý J
Neoplasma; 2006; 53(1):26-9. PubMed ID: 16416009
[TBL] [Abstract][Full Text] [Related]
14. Circulating sCD138 and some angiogenesis-involved cytokines help to anticipate the disease progression of early-stage B-cell chronic lymphocytic leukemia.
Wołowiec D; Dybko J; Wróbel T; Urbaniak-Kujda D; Jaźwiec B; Tomaszewska-Toporska B; Kapelko-Słowik K; Potoczek S; Kuliczkowski K
Mediators Inflamm; 2006; 2006(3):42394. PubMed ID: 16951490
[TBL] [Abstract][Full Text] [Related]
15. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.
Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Karkantaris C; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Pizzolo G; Pangalis GA
Haematologica; 2002 Jul; 87(7):701-8; discussion 708. PubMed ID: 12091120
[TBL] [Abstract][Full Text] [Related]
17. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
[TBL] [Abstract][Full Text] [Related]
18. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
19. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
Tzankov A; Zimpfer A; Pehrs AC; Lugli A; Went P; Maurer R; Pileri S; Dirnhofer S
Mod Pathol; 2003 Nov; 16(11):1141-7. PubMed ID: 14614054
[TBL] [Abstract][Full Text] [Related]
20. Serum syndecan-1 in patients with newly diagnosed monoclonal proteinemia.
Schaar CG; Vermeer HJ; Wijermans PW; Huisman W; le Cessie S; Kluin-Nelemans HC
Haematologica; 2005 Oct; 90(10):1437-8. PubMed ID: 16219583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
